Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Dentsply Sirona (XRAY) over the last 17 years, with Q3 2025 value amounting to $397.0 million.

  • Dentsply Sirona's Operating Expenses fell 1236.2% to $397.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1026.91%. This contributed to the annual value of $1.8 billion for FY2024, which is 219.96% down from last year.
  • According to the latest figures from Q3 2025, Dentsply Sirona's Operating Expenses is $397.0 million, which was down 1236.2% from $383.0 million recorded in Q2 2025.
  • In the past 5 years, Dentsply Sirona's Operating Expenses ranged from a high of $521.0 million in Q1 2023 and a low of $383.0 million during Q2 2025
  • Its 5-year average for Operating Expenses is $441.4 million, with a median of $445.0 million in 2022.
  • As far as peak fluctuations go, Dentsply Sirona's Operating Expenses soared by 5750.0% in 2021, and later crashed by 1691.97% in 2025.
  • Quarter analysis of 5 years shows Dentsply Sirona's Operating Expenses stood at $432.0 million in 2021, then increased by 3.24% to $446.0 million in 2022, then increased by 0.67% to $449.0 million in 2023, then grew by 0.45% to $451.0 million in 2024, then decreased by 11.97% to $397.0 million in 2025.
  • Its Operating Expenses stands at $397.0 million for Q3 2025, versus $383.0 million for Q2 2025 and $403.0 million for Q1 2025.